ArticleAdvances and applications in bioinformatics and chemistry : AABC2024
Non-Invasive Cancer Detection Using Blood Test and Predictive Modeling Approach.
Article in Advances and applications in bioinformatics and chemistry : AABC, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The use of blood test trends in cancer detection: a scoping review.Diagnostic and prognostic research · 2026Review
- Machine Learning-Based Detection of Parkinson's Disease From Arabic Speech: A Cross-Linguistic Validation Study.Journal of central nervous system disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The incidence of cancer, which is a serious public health concern, is increasing. A predictive analysis driven by machine learning was integrated with haematology parameters to create a method for the simultaneous diagnosis of several malignancies at different stages. Patients and Methods: We analysed a newly collected dataset from various hospitals in Jordan comprising 19,537 laboratory reports (6,280 cancer and 13,257 noncancer cases). To clean and obtain the data ready for modelling, preprocessing steps such as feature standardization and missing value removal were used. Several cutting-edge classifiers were employed for the prediction analysis. In addition, we experimented with the dataset's missing values using the histogram gradient boosting (HGB) model. Results: The feature ranking method demonstrated the ability to distinguish cancer patients from healthy individuals based on hematological features such as WBCs, red blood cell (RBC) counts, and platelet (PLT) counts, in addition to age and creatinine level. The random forest (RF) classifier, followed by linear discriminant analysis (LDA) and support vector machine (SVM), achieved the highest prediction accuracy (ranging from 0.69 to 0.72 depending on the scenario and method investigated), reliably distinguishing between malignant and benign conditions. The HGB model showed improved performance on the dataset. Conclusion: After investigating a number of machine learning methods, an efficient screening platform for non-invasive cancer detection is provided by the integration of haematological indicators with proper analytical data. Exploring deep learning methods in the future work, could provide insights into more complex patterns within the dataset, potentially improving the accuracy and robustness of the predictions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.